drugset / Trial / NCT03996434

Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS

NCT03996434

RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this work is to study the value of GnRH antagonist subcutaneous administration as an alternative to coasting in prevention of severe OHSS and its impact on embryos quality \& the outcome of ICSI.

Timeline

Start
2019-07-01
Primary completion
2019-11-10
Completion
2019-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetrorelix Other / unclassified 0.25 mg Subcutaneous